These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31535183)

  • 1. Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors.
    Bennett JS; Bernhardt M; McBride KL; Reshmi SC; Zmuda E; Kertesz NJ; Garg V; Fitzgerald-Butt S; Kamp AN
    Pediatr Cardiol; 2019 Dec; 40(8):1679-1687. PubMed ID: 31535183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric Patients.
    SoRelle JA; Thodeson DM; Arnold S; Gotway G; Park JY
    JAMA Pediatr; 2019 Jan; 173(1):e182302. PubMed ID: 30398534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency of gene variant reclassification and its impact on clinical management in the inherited arrhythmia clinic.
    Young WJ; Maung S; Ahmet S; Kirkby C; Ives C; Schilling RJ; Lowe M; Lambiase PD
    Heart Rhythm; 2024 Jun; 21(6):903-910. PubMed ID: 38218330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
    So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
    Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritize Variant Reclassification in Pediatric Long QT Syndrome-Time to Revisit.
    Leung HT; Kwok SY; Kwong KY; Shih FY; Tsao S; Chung BH
    Pediatr Cardiol; 2024 Jun; 45(5):1023-1035. PubMed ID: 38565666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
    Andreis TF; de Souza KIW; Vieira IA; Alemar B; Sinigaglia M; de Araújo Rocha YM; Artigalás O; Bittar C; Oliveira Netto CB; Ashton-Prolla P; Rosset C
    Gene; 2023 Apr; 862():147281. PubMed ID: 36775216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay.
    Hu C; Susswein LR; Roberts ME; Yang H; Marshall ML; Hiraki S; Berkofsky-Fessler W; Gupta S; Shen W; Dunn CA; Huang H; Na J; Domchek SM; Yadav S; Monteiro ANA; Polley EC; Hart SN; Hruska KS; Couch FJ
    Clin Cancer Res; 2022 Sep; 28(17):3742-3751. PubMed ID: 35736817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic yield from cardiac gene testing for inherited cardiac conditions and re-evaluation of pre-ACMG variants of uncertain significance.
    Murphy J; Kirk CW; Lambert DM; McGorrian C; Walsh R; McVeigh TP; Prendiville T; Ward D; Galvin J; Lynch SA
    Ir J Med Sci; 2024 Aug; 193(4):1775-1785. PubMed ID: 38489124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for
    Innella G; Ferrari S; Miccoli S; Luppi E; Fortuno C; Parsons MT; Spurdle AB; Turchetti D
    J Med Genet; 2024 Apr; 61(5):483-489. PubMed ID: 38160042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Re-evaluation of variants of uncertain significance in patients with hereditary arrhythmogenic disorders".
    Martin S; Jenewein T; Geisen C; Scheiper-Welling S; Kauferstein S
    BMC Cardiovasc Disord; 2024 Jul; 24(1):390. PubMed ID: 39068400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
    Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
    Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting reclassification of variants of unknown significance.
    Wright M; Menon V; Taylor L; Shashidharan M; Westercamp T; Ternent CA
    Am J Surg; 2018 Dec; 216(6):1148-1154. PubMed ID: 30217367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant classification changes over time in the clinical molecular diagnostic laboratory setting.
    Hahn E; Mighton C; Fisher Y; Wong A; Di Gioacchino V; Watkins N; Mayers J; Bombard Y; Charames GS; Lerner-Ellis J
    J Med Genet; 2024 Jul; 61(8):788-793. PubMed ID: 38806232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinterpretation of Chromosomal Microarrays with Detailed Medical History.
    Farooqi MS; Figueroa S; Gotway G; Wang J; Luu HS; Park JY
    J Pediatr; 2020 Jul; 222():180-185.e1. PubMed ID: 32417076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessment of the NF1 variants of unknown significance found during the 20-year activity of a genetics diagnostic laboratory.
    Martorana D; Barili V; Uliana V; Ambrosini E; Riva M; De Sensi E; Luppi E; Messina C; Caleffi E; Pisani F; Percesepe A
    Eur J Med Genet; 2023 Nov; 66(11):104847. PubMed ID: 37751797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.
    Scherr CL; Lindor NM; Malo TL; Couch FJ; Vadaparampil ST
    Clin Genet; 2015 Dec; 88(6):523-9. PubMed ID: 25640009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study.
    Glazer AM; Davogustto G; Shaffer CM; Vanoye CG; Desai RR; Farber-Eger EH; Dikilitas O; Shang N; Pacheco JA; Yang T; Muhammad A; Mosley JD; Van Driest SL; Wells QS; Shaffer LL; Kalash OR; Wada Y; Bland HT; Yoneda ZT; Mitchell DW; Kroncke BM; Kullo IJ; Jarvik GP; Gordon AS; Larson EB; Manolio TA; Mirshahi T; Luo JZ; Schaid D; Namjou B; Alsaied T; Singh R; Singhal A; Liu C; Weng C; Hripcsak G; Ralston JD; McNally EM; Chung WK; Carrell DS; Leppig KA; Hakonarson H; Sleiman P; Sohn S; Glessner J; ; Denny J; Wei WQ; George AL; Shoemaker MB; Roden DM
    Circulation; 2022 Mar; 145(12):877-891. PubMed ID: 34930020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience of reassessing
    Yoon E; Lee JK; Park TK; Chang SA; Huh J; Kim JW; Kim DK; Jang JH
    J Med Genet; 2023 Dec; 61(1):57-60. PubMed ID: 37558401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observed frequency and challenges of variant reclassification in a hereditary cancer clinic.
    Macklin S; Durand N; Atwal P; Hines S
    Genet Med; 2018 Mar; 20(3):346-350. PubMed ID: 29215655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.